Author Question: A client is experiencing intense pruritis from contact dermatitis. Which of the following would be ... (Read 67 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
A client is experiencing intense pruritis from contact dermatitis. Which of the following would be helpful for this client?
 
  1. Administer hydroxyzine HCL as prescribed.
  2. Cover the area with a warm compress.
  3. Instruct to scratch the skin with finger pads.
  4. Increase ambulation when itching occurs.

Question 2

A client is prescribed to receive a nasogastric (NG) tube feeding. The nurse realizes that:
 
  1. placement does not need to be checked before the feeding.
  2. an NG tube is for long-term uses.
  3. the head of the bed must be 30 degrees or greater.
  4. feeding the client is not a reason for an NG tube.



frogdreck123456

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

1
Hydroxyzine HCL is an antihistamine used to relieve pruritis associated with contact dermatitis. Covering the area with a warm compress could cause the area to itch more. The client should be instructed to avoid scratching. Ambulation will not help reduce the itchiness.

Answer to Question 2

3
The head of the client's bed must be at least 30 degrees to decrease the risk of aspiration during feeding. Placement must be checked prior to feeding, and NG tubes are not for long-term use.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

The average office desk has 400 times more bacteria on it than a toilet.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library